These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 16581249)
1. Gankyrin: a new oncoprotein and regulator of pRb and p53. Dawson S; Higashitsuji H; Wilkinson AJ; Fujita J; Mayer RJ Trends Cell Biol; 2006 May; 16(5):229-33. PubMed ID: 16581249 [TBL] [Abstract][Full Text] [Related]
2. Gankyrin, the 26 S proteasome, the cell cycle and cancer. Mayer RJ; Fujita J Biochem Soc Trans; 2006 Nov; 34(Pt 5):746-8. PubMed ID: 17052188 [TBL] [Abstract][Full Text] [Related]
3. Structure of the oncoprotein gankyrin in complex with S6 ATPase of the 26S proteasome. Nakamura Y; Nakano K; Umehara T; Kimura M; Hayashizaki Y; Tanaka A; Horikoshi M; Padmanabhan B; Yokoyama S Structure; 2007 Feb; 15(2):179-89. PubMed ID: 17292836 [TBL] [Abstract][Full Text] [Related]
4. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Higashitsuji H; Higashitsuji H; Itoh K; Sakurai T; Nagao T; Sumitomo Y; Masuda T; Dawson S; Shimada Y; Mayer RJ; Fujita J Cancer Cell; 2005 Jul; 8(1):75-87. PubMed ID: 16023600 [TBL] [Abstract][Full Text] [Related]
5. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation. Higashitsuji H; Liu Y; Mayer RJ; Fujita J Cell Cycle; 2005 Oct; 4(10):1335-7. PubMed ID: 16177571 [TBL] [Abstract][Full Text] [Related]
6. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Higashitsuji H; Itoh K; Nagao T; Dawson S; Nonoguchi K; Kido T; Mayer RJ; Arii S; Fujita J Nat Med; 2000 Jan; 6(1):96-9. PubMed ID: 10613832 [TBL] [Abstract][Full Text] [Related]
7. Gankyrin: an intriguing name for a novel regulator of p53 and RB. Lozano G; Zambetti GP Cancer Cell; 2005 Jul; 8(1):3-4. PubMed ID: 16023592 [TBL] [Abstract][Full Text] [Related]
8. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells. Qiu W; Wu J; Walsh EM; Zhang Y; Chen CY; Fujita J; Xiao ZX Oncogene; 2008 Jul; 27(29):4034-43. PubMed ID: 18332869 [TBL] [Abstract][Full Text] [Related]
9. Gankyrin promotes the proliferation of human pancreatic cancer. Meng Y; He L; Guo X; Tang S; Zhao X; Du R; Jin J; Bi Q; Li H; Nie Y; Liu J; Fan D Cancer Lett; 2010 Nov; 297(1):9-17. PubMed ID: 20483533 [TBL] [Abstract][Full Text] [Related]
10. Structural basis for the recognition between the regulatory particles Nas6 and Rpt3 of the yeast 26S proteasome. Nakamura Y; Umehara T; Tanaka A; Horikoshi M; Padmanabhan B; Yokoyama S Biochem Biophys Res Commun; 2007 Aug; 359(3):503-9. PubMed ID: 17555716 [TBL] [Abstract][Full Text] [Related]
11. Crystallization of gankyrin, an oncoprotein that interacts with CDK4 and the S6b (rpt3) ATPase of the 19S regulator of the 26S proteasome. Krzywda S; Brzozowski AM; Al-Safty R; Welchman R; Mee M; Dawson S; Fujita J; Higashitsuji H; Mayer RJ; Wilkinson AJ Acta Crystallogr D Biol Crystallogr; 2003 Jul; 59(Pt 7):1294-5. PubMed ID: 12832791 [TBL] [Abstract][Full Text] [Related]
12. Effects of MdmX on Mdm2-mediated downregulation of pRB. Uchida C; Miwa S; Isobe T; Kitagawa K; Hattori T; Oda T; Yasuda H; Kitagawa M FEBS Lett; 2006 Mar; 580(7):1753-8. PubMed ID: 16510145 [TBL] [Abstract][Full Text] [Related]
13. The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53. Krzywda S; Brzozowski AM; Higashitsuji H; Fujita J; Welchman R; Dawson S; Mayer RJ; Wilkinson AJ J Biol Chem; 2004 Jan; 279(2):1541-5. PubMed ID: 14573599 [TBL] [Abstract][Full Text] [Related]
14. Functional characterization of human oncoprotein gankyrin in Zebrafish. Kim SY; Hur W; Choi JE; Kim D; Wang JS; Yoon HY; Piao LS; Yoon SK Exp Mol Med; 2009 Jan; 41(1):8-16. PubMed ID: 19287195 [TBL] [Abstract][Full Text] [Related]
15. Expression of the oncoprotein gankyrin and phosphorylated retinoblastoma protein in human testis and testicular germ cell tumor. Ando S; Matsuoka T; Kawai K; Sugita S; Joraku A; Kojima T; Suetomi T; Miyazaki J; Fujita J; Nishiyama H Int J Urol; 2014 Oct; 21(10):992-8. PubMed ID: 24861729 [TBL] [Abstract][Full Text] [Related]
16. The role of p28GANK in rat oval cells activation and proliferation. Shan YF; Zhou WP; Fu XY; Yan HX; Yang W; Liu SQ; Cao HF; Kang B; Wu MC; Wang HY Liver Int; 2006 Mar; 26(2):240-7. PubMed ID: 16448463 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53. Kuo TC; Chang PY; Huang SF; Chou CK; Chao CC Biochem Pharmacol; 2012 Mar; 83(6):758-68. PubMed ID: 22230478 [TBL] [Abstract][Full Text] [Related]
18. p53-independent pRB degradation contributes to a drug-induced apoptosis in AGS cells. Jin Y; Leung WK; Sung JJ; Wu JR Cell Res; 2005 Sep; 15(9):695-703. PubMed ID: 16212876 [TBL] [Abstract][Full Text] [Related]
19. Role of a novel oncogenic protein, gankyrin, in hepatocyte proliferation. Iwai A; Marusawa H; Kiuchi T; Higashitsuji H; Tanaka K; Fujita J; Chiba T J Gastroenterol; 2003; 38(8):751-8. PubMed ID: 14505129 [TBL] [Abstract][Full Text] [Related]
20. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells. Sun W; Ding J; Wu K; Ning BF; Wen W; Sun HY; Han T; Huang L; Dong LW; Yang W; Deng X; Li Z; Wu MC; Feng GS; Xie WF; Wang HY Hepatology; 2011 Oct; 54(4):1259-72. PubMed ID: 21735473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]